Global Angong Niuhuang Pill Market Segment Research Report 2024
Summary
The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.
2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.
According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.
Beijing Yanjing Bizhi Information Consulting Co., Ltd. （XYZResearch）released the 《(Post-pandemic Era)-Global Angong Niuhuang Pill Market Segment Research Report 2022》, which aims to sort out the development status and trends of the Angong Niuhuang Pill industry at home and abroad, estimate the overall market scale of the Angong Niuhuang Pill industry and the market share of major countries, Angong Niuhuang Pill industry, and study and judge the downstream market demand of Angong Niuhuang Pill through systematic research, Analyze the competition pattern of Angong Niuhuang Pill, so as to help solve the pain points of various stakeholders in Angong Niuhuang Pill industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.
Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of Angong Niuhuang Pill Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Angong Niuhuang Pill Market?
Beijing TRT Group
GuangYuYuan Chinese Herbal Medicine Co.,Ltd.
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
Mapakleung Co., Ltd
Jiuzhitang Co., Ltd.
Wai Yuen Tong Medicine Co.,Ltd.
Tianjin Zhongxin Pharmaceutical Group Corporation Limited
Hangzhou HU QING YU TANG Pharmaceutical Co., Ltd.
Shandong Hongjitang Co., Ltd.
Sinopharm Group Fengliaoxing (Foshan) Pharmaceutical Co., Ltd.
Major Type of Angong Niuhuang Pill Covered in XYZResearch report
Natural Ingredients
Synthetic Ingredients
Application Segments Covered in XYZResearch Market
Stroke
Coma
Centric Fever
Viral Encephalitis
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Content
Table of Contents
Global Angong Niuhuang Pill Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Angong Niuhuang Pill Market by Value
2.2.1 Global Angong Niuhuang Pill Revenue by Type
2.2.2 Global Angong Niuhuang Pill Market by Value (%)
2.3 Global Angong Niuhuang Pill Market by Production
2.3.1 Global Angong Niuhuang Pill Production by Type
2.3.2 Global Angong Niuhuang Pill Market by Production (%)
3. The Major Driver of Angong Niuhuang Pill Industry
3.1 Historical & Forecast Global Angong Niuhuang Pill Demand
3.2 Largest Application for Angong Niuhuang Pill (2018-2028)
3.3 The Major Downstream Company in China Market 2022
4. Global and Regional Angong Niuhuang Pill Market
4.1 Regional Market Size in Terms of Production & Demand (2022)
4.2 Regional Market Share in Terms of Revenue (2018-2022)
4.3 Concentration Ratio (CR5& CR10) of Angong Niuhuang Pill Market
4.4 Mergers & Acquisitions, Expansion Plans
5. US Angong Niuhuang Pill Production, Revenue (2018-2028)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Production Breakdown by Application
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
6. Europe Angong Niuhuang Pill Production, Revenue (2018-2028)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Production Breakdown by Application
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
7. China Angong Niuhuang Pill Production, Revenue (2018-2028)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Production Breakdown by Application
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
8. Japan Angong Niuhuang Pill Production, Revenue (2018-2028)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Production Breakdown by Application
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
9. India Angong Niuhuang Pill Production, Revenue (2018-2028)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Production Breakdown by Application
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
10. Korea Angong Niuhuang Pill Production, Revenue (2018-2028)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Production Breakdown by Application
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
11. Southeast Asia Angong Niuhuang Pill Production, Revenue (2018-2028)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Production Breakdown by Application
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
12. Global Angong Niuhuang Pill Average Price Trend
12.1 Market Price for Each Type of Angong Niuhuang Pill in US (2018-2022)
12.2 Market Price for Each Type of Angong Niuhuang Pill in Europe (2018-2022)
12.3 Market Price for Each Type of Angong Niuhuang Pill in China (2018-2022)
12.4 Market Price for Each Type of Angong Niuhuang Pill in Japan (2018-2022)
12.5 Market Price for Each Type of Angong Niuhuang Pill in India (2018-2022)
12.6 Market Price for Each Type of Angong Niuhuang Pill in Korea (2018-2022)
12.7 Market Price for Each Type of Angong Niuhuang Pill in Southeast Asia (2018-2022)
13. Industrial Chain (Impact of COVID-19)
13.1 Angong Niuhuang Pill Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Post-pandemic Era
13.5 Technology Trends of Angong Niuhuang Pill
14. Angong Niuhuang Pill Competitive Landscape
14.1 Beijing TRT Group
14.1.1 Beijing TRT Group Company Profiles
14.1.2 Beijing TRT Group Product Introduction
14.1.3 Beijing TRT Group Angong Niuhuang Pill Production, Revenue (2018-2022)
14.1.4 Strategic initiatives
14.2 GuangYuYuan Chinese Herbal Medicine Co.,Ltd.
14.2.1 GuangYuYuan Chinese Herbal Medicine Co.,Ltd. Company Profiles
14.2.2 GuangYuYuan Chinese Herbal Medicine Co.,Ltd. Product Introduction
14.2.3 GuangYuYuan Chinese Herbal Medicine Co.,Ltd. Angong Niuhuang Pill Production, Revenue (2018-2022)
14.2.4 Strategic initiatives
14.3 Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
14.3.1 Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Company Profiles
14.3.2 Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Product Introduction
14.3.3 Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Angong Niuhuang Pill Production, Revenue (2018-2022)
14.3.4 Strategic initiatives
14.4 Mapakleung Co., Ltd
14.4.1 Mapakleung Co., Ltd Company Profiles
14.4.2 Mapakleung Co., Ltd Product Introduction
14.4.3 Mapakleung Co., Ltd Angong Niuhuang Pill Production, Revenue (2018-2022)
14.4.4 Strategic initiatives
14.5 Jiuzhitang Co., Ltd.
14.5.1 Jiuzhitang Co., Ltd. Company Profiles
14.5.2 Jiuzhitang Co., Ltd. Product Introduction
14.5.3 Jiuzhitang Co., Ltd. Angong Niuhuang Pill Production, Revenue (2018-2022)
14.5.4 Strategic initiatives
14.6 Wai Yuen Tong Medicine Co.,Ltd.
14.6.1 Wai Yuen Tong Medicine Co.,Ltd. Company Profiles
14.6.2 Wai Yuen Tong Medicine Co.,Ltd. Product Introduction
14.6.3 Wai Yuen Tong Medicine Co.,Ltd. Angong Niuhuang Pill Production, Revenue (2018-2022)
14.6.4 Strategic initiatives
14.7 Tianjin Zhongxin Pharmaceutical Group Corporation Limited
14.7.1 Tianjin Zhongxin Pharmaceutical Group Corporation Limited Company Profiles
14.7.2 Tianjin Zhongxin Pharmaceutical Group Corporation Limited Product Introduction
14.7.3 Tianjin Zhongxin Pharmaceutical Group Corporation Limited Angong Niuhuang Pill Production, Revenue (2018-2022)
14.7.4 Strategic initiatives
14.8 Hangzhou HU QING YU TANG Pharmaceutical Co., Ltd.
14.8.1 Hangzhou HU QING YU TANG Pharmaceutical Co., Ltd. Company Profiles
14.8.2 Hangzhou HU QING YU TANG Pharmaceutical Co., Ltd. Product Introduction
14.8.3 Hangzhou HU QING YU TANG Pharmaceutical Co., Ltd. Angong Niuhuang Pill Production, Revenue (2018-2022)
14.8.4 Strategic initiatives
14.9 Shandong Hongjitang Co., Ltd.
14.9.1 Shandong Hongjitang Co., Ltd. Company Profiles
14.9.2 Shandong Hongjitang Co., Ltd. Product Introduction
14.9.3 Shandong Hongjitang Co., Ltd. Angong Niuhuang Pill Production, Revenue (2018-2022)
14.9.4 Strategic initiatives
14.10 Sinopharm Group Fengliaoxing (Foshan) Pharmaceutical Co., Ltd.
14.10.1 Sinopharm Group Fengliaoxing (Foshan) Pharmaceutical Co., Ltd. Company Profiles
14.10.2 Sinopharm Group Fengliaoxing (Foshan) Pharmaceutical Co., Ltd. Product Introduction
14.10.3 Sinopharm Group Fengliaoxing (Foshan) Pharmaceutical Co., Ltd. Angong Niuhuang Pill Production, Revenue (2018-2022)
14.10.4 Strategic initiatives
15. Conclusion
16. Methodology and Data Source
List of Figure
List of Tables and Figures
Figure 1. Total Demand by Application of Angong Niuhuang Pill Industry (Volume)
Figure 2. Angong Niuhuang Pill Production & Demand by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2027)
Figure 4. The Top 10 and 5 Players Market Share by Angong Niuhuang Pill Revenue in 2022
Figure 5. US Angong Niuhuang Pill Production, Demand (2018-2028)
Figure 6. Production Breakdown by Type (%)
Figure 7. Demand Breakdown by Type (%)
Figure 8. Demand Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Angong Niuhuang Pill Production, Demand (2018-2028)
Figure 12. Production Breakdown by Type (%)
Figure 13. Demand Breakdown by Type (%)
Figure 14. Demand Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Angong Niuhuang Pill Production, Demand (2018-2028)
Figure 18. Production Breakdown by Type (%)
Figure 19. Demand Breakdown by Type (%)
Figure 20. Demand Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Angong Niuhuang Pill Production, Demand (2018-2028)
Figure 25. Production Breakdown by Type (%)
Figure 26. Demand Breakdown by Type (%)
Figure 27. Demand Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Angong Niuhuang Pill Production, Demand (2018-2028)
Figure 31. Production Breakdown by Type (%)
Figure 32. Demand Breakdown by Type (%)
Figure 33. Demand Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Angong Niuhuang Pill Production, Demand (2018-2028)
Figure 37. Production Breakdown by Type (%)
Figure 38. Demand Breakdown by Type (%)
Figure 39. Demand Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Angong Niuhuang Pill Production, Demand (2018-2028)
Figure 43. Current and Estimated Production Breakdown by Type (2018-2028)
Figure 44. Production Breakdown by Type (%)
Figure 45. Demand Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Angong Niuhuang Pill Revenue, by Type (Million USD) (2018-2028)
Table 4. Angong Niuhuang Pill Production, by Type (K Unit) (2018-2028)
Table 5. Angong Niuhuang Pill Demand (K Unit) by Application (2018-2028)
Table 6. Angong Niuhuang Pill Demand (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Production & Demand (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2027)
Table 10. Ranking of Global Top Angong Niuhuang Pill Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Angong Niuhuang Pill Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 13. Current and Estimated Production Breakdown by Type (2018-2028)
Table 14. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 15. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Angong Niuhuang Pill Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 19. Current and Estimated Production Breakdown by Type (2018-2028)
Table 20. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 21. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Angong Niuhuang Pill Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 25. Table Current and Estimated Production Breakdown by Type
Table 26. Current and Estimated Demand Breakdown by Type
Table 27. Current and Estimated Demand Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Angong Niuhuang Pill Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 30. Current and Estimated Production Breakdown by Type (2018-2028)
Table 31. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 32. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Angong Niuhuang Pill Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 36. Current and Estimated Production Breakdown by Type (2018-2028)
Table 37. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 38. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Angong Niuhuang Pill Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 42. Current and Estimated Production Breakdown by Type (2018-2028)
Table 43. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 44. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Angong Niuhuang Pill Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 48. Table Current and Estimated Demand Breakdown by Type (2018-2028)
Table 49. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Angong Niuhuang Pill in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Angong Niuhuang Pill in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Angong Niuhuang Pill in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Angong Niuhuang Pill in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Angong Niuhuang Pill in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Angong Niuhuang Pill in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Angong Niuhuang Pill in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Beijing TRT Group Profiles
Table 61. Beijing TRT Group Angong Niuhuang Pill Product Introduction
Table 62. Beijing TRT Group Angong Niuhuang Pill Production (Unit), Revenue (Million USD) (2018-2022)
Table 63. Beijing TRT Group Strategic initiatives
Table 64. GuangYuYuan Chinese Herbal Medicine Co.,Ltd. Profiles
Table 65. GuangYuYuan Chinese Herbal Medicine Co.,Ltd. Angong Niuhuang Pill Product Introduction
Table 66. GuangYuYuan Chinese Herbal Medicine Co.,Ltd. Angong Niuhuang Pill Production (Unit), Revenue (Million USD) (2018-2022)
Table 67. GuangYuYuan Chinese Herbal Medicine Co.,Ltd. Strategic initiatives
Table 68. Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Profiles
Table 69. Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Angong Niuhuang Pill Product Introduction
Table 70. Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Angong Niuhuang Pill Production (Unit), Revenue (Million USD) (2018-2022)
Table 71. Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Strategic initiatives
Table 72. Mapakleung Co., Ltd Profiles
Table 73. Mapakleung Co., Ltd Angong Niuhuang Pill Product Introduction
Table 74. Mapakleung Co., Ltd Angong Niuhuang Pill Production (Unit), Revenue (Million USD) (2018-2022)
Table 75. Mapakleung Co., Ltd Strategic initiatives
Table 76. Jiuzhitang Co., Ltd. Profiles
Table 77. Jiuzhitang Co., Ltd. Angong Niuhuang Pill Product Introduction
Table 78. Jiuzhitang Co., Ltd. Angong Niuhuang Pill Production (Unit), Revenue (Million USD) (2018-2022)
Table 79. Jiuzhitang Co., Ltd. Strategic initiatives
Table 80. Wai Yuen Tong Medicine Co.,Ltd. Profiles
Table 81. Wai Yuen Tong Medicine Co.,Ltd. Angong Niuhuang Pill Product Introduction
Table 82. Wai Yuen Tong Medicine Co.,Ltd. Angong Niuhuang Pill Production (Unit), Revenue (Million USD) (2018-2022)
Table 83. Wai Yuen Tong Medicine Co.,Ltd. Strategic initiatives
Table 84. Tianjin Zhongxin Pharmaceutical Group Corporation Limited Profiles
Table 85. Tianjin Zhongxin Pharmaceutical Group Corporation Limited Angong Niuhuang Pill Product Introduction
Table 86. Tianjin Zhongxin Pharmaceutical Group Corporation Limited Angong Niuhuang Pill Production (Unit), Revenue (Million USD) (2018-2022)
Table 87. Tianjin Zhongxin Pharmaceutical Group Corporation Limited Strategic initiatives
Table 88. Hangzhou HU QING YU TANG Pharmaceutical Co., Ltd. Profiles
Table 89. Hangzhou HU QING YU TANG Pharmaceutical Co., Ltd. Angong Niuhuang Pill Product Introduction
Table 90. Hangzhou HU QING YU TANG Pharmaceutical Co., Ltd. Angong Niuhuang Pill Production (Unit), Revenue (Million USD) (2018-2022)
Table 91. Hangzhou HU QING YU TANG Pharmaceutical Co., Ltd. Strategic initiatives
Table 92. Shandong Hongjitang Co., Ltd. Profiles
Table 93. Shandong Hongjitang Co., Ltd. Angong Niuhuang Pill Product Introduction
Table 94. Shandong Hongjitang Co., Ltd. Angong Niuhuang Pill Production (Unit), Revenue (Million USD) (2018-2022)
Table 95. Shandong Hongjitang Co., Ltd. Strategic initiatives
Table 97. Sinopharm Group Fengliaoxing (Foshan) Pharmaceutical Co., Ltd. Profiles
Table 98. Sinopharm Group Fengliaoxing (Foshan) Pharmaceutical Co., Ltd. Angong Niuhuang Pill Product Introduction
Table 99. Sinopharm Group Fengliaoxing (Foshan) Pharmaceutical Co., Ltd. Angong Niuhuang Pill Production (Unit), Revenue (Million USD) (2018-2022)
Table 100. Sinopharm Group Fengliaoxing (Foshan) Pharmaceutical Co., Ltd. Strategic initiatives
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices